Meeting Agenda (All Times Pacific)PDF AgendaRegister Now

Wednesday, November 1, 2023Free Session Registration

SYMPOSIUM: STANDARDIZATION OF CGM PERFORMANCE EVALUATIONS – DEVELOPMENTS FROM THE IFCC WORKING GROUP ON CGM

7:30

Welcome and Introduction

Guido Freckmann, MD
Institute for Diabetes Technology at Ulm University, Ulm, Germany

Johan H. Jendle, MD, PhD
Örebro University, Örebro, Sweden

7:35

CGM Accuracy: Contrasting CE Marking with the Governmental Controls of the USA and Australia

John Pemberton, BSc
Department of Endocrinology and Diabetes, Birmingham Children’s Hospital, Birmingham Women’s, and Children’s NHS Foundation Trust, Birmingham, UK

7:56

A Scoping Review of CGM Performance Evaluations from the Last 20 Years

Stefan Pleus, PhD
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany

8:17

Comparison Measurement Approaches for CGM Performance Studies

Rolf Hinzmann, MD, PhD
Roche Diabetes Care, Mannheim, Germany

8:38

Standardized Testing Procedures for the Clinical Performance Evaluation of CGM Systems: A Proposal by the IFCC Working Group on CGM

Guido Freckmann, MD
Institute for Diabetes Technology at Ulm University, Ulm, Germany

9:00

Break

MEET THE PROFESSORS

9:15

Moderator

David T. Ahn, MD
Mary & Dick Allen Diabetes Center, Hoag Memorial Hospital Presbyterian, Newport Beach, California, USA

9:15

Viral N. Shah, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA

9:45

Joseph Wang, PhD
University of California, San Diego, San Diego, California, USA

10:15

Lutz Heinemann, PhD
Science Consulting in Diabetes, Düsseldorf, Germany

PRODUCT THEATER SESSIONS

11:00

Dexcom Presents: Dexcom Technology:  Continuous Improvements, Optimization and Near Term Advancements

Peter Simpson
Sr. Vice President, R&D; Dexcom Inc.

11:20

Dexcom Presents: The Growing Use of rtCGM in Non-Insulin Type 2 Diabetes:  Clinical Outcomes and Patient Experience in Real-World Practice

Thomas Grace, MD
Head, Clinical Advocacy and Outcomes; Dexcom, Inc.

11:40

Dexcom Presents: Dexcom CGM in Pregnancy: Review of the AiDAPT Study and G7 Accuracy in Pregnancy

Carol J. Levy, MD, CDCES
Professor of Medicine and Obstetrics; Director Mount Sinai Diabetes Center; Associate System Chief for Clinical Research, Division of Endocrinology, Diabetes, and Metabolism; Icahn School of Medicine at Mount Sinai

12:00

Tandem Diabetes Care Presents: Control-IQ Technology Made Easy

Laurel Messer, PhD, RN, CDCES
Senior Director, Translational Research & Applied Science, Tandem Diabetes Care

Thursday, November 2, 2023

WORKSHOP A: DIGITAL HEALTH TOOLS

PANEL 1:  INTERACTIVE APPS FOR BEHAVIORAL CHANGE

Can apps modify behavior?

8:00

Moderators

William Polonsky, PhD
Behavioral Diabetes Institute, San Diego, California, USA

Michelle L. Litchman, PhD, FNP-BC, FAANP, FADCES, FAAN
The University of Utah College of Nursing, Salt Lake City, Utah, USA

Panelists

Andrew Farmer, DM, FRCGP
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom

Felix Lee, MPharm, MSc, MBA
Sanofi, Bridgewater, New Jersey, USA

David T. Ahn, MD
Mary & Dick Allen Diabetes Center, Hoag Memorial Hospital Presbyterian, Newport Beach, California, USA

9:40

Break

PANEL 2: TELEHEALTH AND COACHING

How to apply coaching to improve diabetes outcomes?

9:55

Moderators

Warris Bokhari, MBBS
Amazon, Seattle, Washington, USA

David Kerr, MBChB, DM, FRCP, FRCPE
Sutter Health, Santa Barbara, California, USA

Panelists

Wei-An (Andy) Lee, DO
Los Angeles General Medical Center, Los Angeles, California, USA

Anand K. Iyer, PhD, MBA
Welldoc, Inc., Columbia, Maryland, USA

Sacha Uelmen, RDN, CDCES
Association of Diabetes Care & Education Specialists, Chicago, Illinois, USA

11:30

Lunch

WORKSHOP B: METRICS FOR ASSESSING GLYCEMIA AND COMPLICATIONS

PANEL 1: ANALYTICAL AND CLINICAL CGM METRICS

What are the latest metrics for CGM?

12:30

Moderators  

Guillermo Umpierrez, MD
Emory University School of Medicine, Atlanta, Georgia, USA

Eda Cengiz, MD, MHS, FAAP
University of California, San Francisco, School of Medicine, San Francisco, California, USA

12:35

The Glycemia Risk Index

David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA

12:50

Update on Time in Range               

Richard M. Bergenstal, MD
International Diabetes Center, HealthPartners Institute, Minneapolis, Minnesota, USA

13:05

Tight Time in Range            

Viral N. Shah, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA

13:20

Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA)            

Manuel Eichenlaub, PhD
Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany

13:35

Glycemic Ratio for Critically Ill People                 

James S. Krinsley, MD
Division of Critical Care, Stamford Hospital, Columbia University College of Physicians and Surgeons, Stamford, Connecticut, USA

13:50

Q&A / Panel Discussion

14:10

Break

PANEL 2: SENSORS FOR DIAGNOSING COMPLICATIONS IN DIABETES

How can technology identify complications of diabetes?

14:25

Moderators

Michael J. McShane, PhD
Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA

Andjela Drincic, MD
Department of Diabetes, Endocrinology, and Metabolism, University of Nebraska Medical Center, Omaha, Nebraska, USA

14:30

External Eye Screening as an Adjunct to Retinal Screening

Jorge A. Cuadros, OD, PhD
Herbert Wertheim School of Optometry and Vision Science, University of California, Berkeley, Berkeley, California, USA

14:45

Monitoring Exercise for Precision Diabetes

Michael C. Riddell, PhD
Department of Kinesiology & Health Science, Muscle Health Research Centre, York University, Toronto, ON, Canada

15:00

A Multimodal Sensor Panel for Diabetes

Gerard L. Coté, PhD
Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA

15:15

IEEE 2621: The Diabetes Device Cybersecurity Standard

Ted Osinski
Institute of Electrical and Electronics Engineers, Piscataway, New Jersey, USA

15:30

Racial-Ethnic Disparities in Wearable Diabetes Devices

Devin W. Steenkamp, MBChB
Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA

15:45

Q&A / Panel Discussion

16:05

Adjourn

Friday, November 3, 2023

8:00

Introduction

David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA

8:05

iCoDE 1 and 2

Juan Espinoza, MD, FAAP
Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois, USA

8:25

Q&A

SESSION 1: DIABETES DATA SCIENCE

How can data predict and prevent complications of diabetes?

8:30

Moderators  

William T. Cefalu, MD
Division of Diabetes, Endocrinology, & Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA

John C. Pickup, MA, DPhil, FRCPath
King’s College London School of Medicine, London, UK

Panelist

Eirik Årsand, PhD
UiT Arctic University of Norway, Tromsø, Norway

8:35

Overview of Diabetes Data Science

Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA

8:55

Precision Monitoring in Diabetes

Norbert Hermanns, PhD
Research Institute of the Diabetes Academy Mergentheim (FIDAM), Bad Mergentheim, Germany

9:15

Digital Twinning Technologies in Type 1 Diabetes

Andrea Facchinetti, PhD
Department of Information Engineering, University of Padova, Padova, Italy

9:35

Q&A / Panel Discussion

SESSION 2: NOVEL INDICATIONS FOR CGM

How can people without diabetes benefit from CGM?

9:50

Moderators

Julia K. Mader, MD
Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Austria

Kong Y. Chen, PhD
National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA

9:55

CGM in People without Diabetes

Tracey L. McLaughlin, MD, MS
Stanford University School of Medicine, Stanford, California, USA

10:10

CGM in Pregnancy

Stephanie A. Fisher, MD, MPH
Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

10:25

CGM in Kidney Disease

Connie M. Rhee, MD, MSc
VA Greater Los Angeles Healthcare System, Los Angeles, California, USA and David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA

10:40

The Use of CGM in the Hospital

Kathleen M. Dungan, MD, MPH
The Ohio State University, Columbus, Ohio, USA

10:55

Q&A / Panel Discussion

11:10

Break

SESSION 3: REGULATION OF DIABETES DEVICES AND DRUGS

What are new trends in FDA regulation of diabetes devices and drugs?

11:25

Moderators

Alberto Gutierrez, PhD
NDA Partners LLC, Bethesda, Maryland, USA

Naomi Schwartz, MS
Medcrypt, Inc., San Diego, California, USA

11:30

Update in Digital Health Regulation

Matthew C. Diamond, MD, PhD
Center for Devices and Radiological Health, United States Food and Drug Administration, Silver Spring, Maryland, USA

11:40

Medical Device Cybersecurity

Jessica Wilkerson, JD
Center for Devices and Radiological Health, United States Food and Drug Administration, Silver Spring, Maryland, USA

11:50

Regulatory Considerations for Comparator Glucose Technology

Deanna Bousalis, PhD
Center for Devices and Radiological Health, United States Food and Drug Administration, Silver Spring, Maryland, USA

12:00

Regulation of Diabetes Drugs

Zan Fleming, MD
Kinexum, Harpers Ferry, West Virginia, USA

12:15

Q&A / Panel Discussion

12:30

Lunch

SESSION 4: PUMP TECHNOLOGY (Non-Accredited Education)

What are the challenges to building a commercially successful insulin pump?

13:00

Moderators

Robert A. Gabbay, MD, PhD
American Diabetes Association, Arlington, Virginia, USA

Douglas Muchmore, MD
La Jolla Endo, LLC, La Jolla, California, USA

13:05

Advances in Infusion Sets

Sarnath Chattaraj, PhD
Medtronic Diabetes, Northridge, California, USA

13:15

Advances in Infusion Set Needles and Cannulas

Jeffrey Joseph, DO
Jefferson Artificial Pancreas Center, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA

13:25

Combining Glucose Monitoring and Insulin Infusion in an Integrated Device: Challenges and Solutions

Lutz Heinemann, PhD
Science Consulting in Diabetes, Düsseldorf, Germany

13:35

Determining Flow Rate from an Insulin Pump

Ralph Ziegler, MD
Diabetes Clinic for Children and Adolescents, Muenster, Germany

13:45

Last Things First – the Importance of Design for Manufacturability

Michael Schoemaker, PhD
Pharmasens AG, Biel, Switzerland

13:55

Q&A / Panel Discussion

SESSION 5: BLOOD GLUCOSE MONITORING TECHNOLOGY (Non-Accredited Education)

What is the role of BGM in various parts of the world?

14:10

Moderators

Hubert W. Vesper, PhD
Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Halis K. Aktürk, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA

14:15

Reference Comparators for BG Sensor Testing

Timothy S. Bailey, MD, FACE, CPI
AMCR Institute, Escondido, California, USA

14:25

Interfering Substances

Andreas Pfützner, MD, PhD
Pfützner Science and Health Institute, Mainz, Germany

14:40

Platforms to Present Glucose Data

Mark A. Clements, MD, PhD, CPI, FAAP
Children's Mercy Hospitals & Clinics, Kansas City, Missouri, USA

14:55

The Role of BGM in Today's World

Yong Mong Bee, MBBS, MRCP(UK), FRCP Edin
Department of Endocrinology, Singapore General Hospital, Singapore

15:10

Q&A / Panel Discussion

15:20

Break

SESSION 6: EMERGING AID TECHNOLOGY

What are the features of a successful AID algorithm?

15:35

Moderators  

Jeffrey Joseph, DO
Jefferson Artificial Pancreas Center, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA

Carol Levy, MD, CDCES
Division of Endocrinology, Diabetes, and Metabolism, Icahn School of Medicine at Mount Sinai, New York City, New York, USA

15:40

Bihormonal Systems: Automating Both Insulin and Glucagon Delivery

Steven J. Russell, MD, PhD
Massachusetts General Hospital Diabetes Research Center, Boston, Massachusetts, USA

15:50

The Loop Algorithm

Rayhan A. Lal, MD
Stanford University, Stanford, California, USA

16:00

AID systems. Are we there yet? A clinician’s perspective.

David N. O'Neal, MD, FRACP, FRCP (Edin)
University of Melbourne, Melbourne, VIC, Australia

16:10

Improving the Performance of an AID system with SGLT2i

Ahmad Haidar, PhD
McGill University, Quebec, Canada

16:20

Personal Patient Experience with Loop

Patient 1

16:25

Personal Patient Experience with Loop

Patient 2

16:30

Q&A / Panel Discussion

16:45

Adjourn

Saturday, November 4, 2023

SESSION 7: DRUGS FOR DIABETES

Which new drugs or indications for diabetes look promising?

8:00

Moderators

Mohammed E. Al Sofiani, MBBS, MSc
King Saud University, Riyadh, Saudi Arabia / Johns Hopkins University, Baltimore, Maryland, USA

Signe Schmidt, MD, PhD
Steno Diabetes Center Copenhagen (SDCC), Copenhagen, Denmark

8:05

Gold Student Award Winner: DR-CIB: an Algorithm for the Preventive Administration of Corrective Insulin Boluses in Type 1 Diabetes based on Dynamic Risk Concept and Patient-Specific Timing

Elisa Pellizzari, MSc
University of Padova, Padova, Italy

8:20

Tirzepatide / Semaglutide for Obesity and T2DM

Eric Zijlstra, PhD
Profil, Neuss, Germany

8:35

Weekly Insulin for Type 1 and Type 2 Diabetes

Ronald Goldenberg, MD, FRCPC, FACE
LMC Diabetes & Endocrinology, Concord, Ontario, Canada

8:50

Inhaled Insulin

Alfonso Galderisi, MD, PhD
Yale University, New Haven, Connecticut, USA

9:05

Tzield/Teplizumab - Why and for Whom?

Stephen E. Gitelman, MD
Division of Endocrinology, Department of Pediatrics, University of California, San Francisco, San Francisco, California, USA

9:20

Q&A / Panel Discussion

SESSION 8: ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING (Non-Accredited Education)

What is the role of AI/ML in diabetes management?

9:35

Moderators                                      

Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA

Riccardo Bellazzi, PhD
Università di Pavia, Pavia, Italy

9:40

Bridge to Artificial Intelligence

Xujing Wang, PhD
Division of Diabetes, Endocrinology, & Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA

9:55

Consensus Guidelines for Using Artificial Intelligence and Machine Learning to Improve Glucose Management in Diabetes: Best Practices, Pitfalls and Opportunities

Peter G. Jacobs, PhD
Oregon Health & Science University, Portland, Oregon, USA

10:10

Uncertainty-aware Nocturnal Hypoglycemia Prediction in People with Type 1 Diabetes on Multiple Daily Injections

Clara Mosquera-Lopez, PhD
Oregon Health & Science University, Portland, Oregon, USA

10:25

Artificial Intelligence for Treating Diabetes

Moshe Phillip, MD
Schneider Children's Medical Center of Israel, Petah Tikva, Israel

10:40

Q&A / Panel Discussion

10:55

Break

SESSION 9: NOVEL ANALYTES FOR DIABETES (Non-Accredited Education)

What should be measured for diabetes besides blood glucose?

11:15

Moderators

Guillermo Arreaza-Rubín, MD
Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA

Alan H.B. Wu, PhD
University of California, San Francisco, San Francisco, CA, USA

11:20

Noninvasive Glucose Monitoring - When Will It Arrive?

Mark A. Arnold, PhD
The University of Iowa, Iowa City, Iowa, USA

11:35

Continuous Ketone Monitoring

Shridhara Alva, PhD
Abbott Diabetes Care, Alameda, California, USA

11:50

Biomarkers Screening for Asymptomatic Heart Failure

Ambarish Pandey, MD
UT Southwestern Medical Center, Dallas, Texas, USA

12:05

Q&A / Panel Discussion

12:20

Lunch

SESSION 10: NEW TECHNOLOGY DEVELOPMENTS IN COMMERCIAL CGMS (Non-Accredited Education)

What is new in CGM technology?

12:50

Moderators

Nestoras Mathioudakis, MD, MHS
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Elias K. Spanakis, MD
Baltimore VA Medical Center and School of Medicine, University of Maryland, Baltimore, Maryland, USA

12:55

Abbott Technology

Anila Bindal, MD
Abbott Diabetes Care, Alameda, California, USA

13:07

Dexcom Technology

Danny Cherñavvsky, MD
Dexcom, Inc., San Diego, California, USA

13:19

Medtronic Technology

Robert Vigersky, MD
Medtronic, Washington, D.C., USA; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA

13:31

Senseonics Technology

Hari Sree, PhD
Senseonics Inc., Germantown, Maryland, USA

13:43

Pacific Diabetes Technologies

Thomas Seidl, PhD
Pacific Diabetes Technologies, Portland, Oregon, USA

13:55

Q&A / Panel Discussion

SESSION 11: SKIN PHYSIOLOGY (Non-Accredited Education)

How does diabetes affect skin health?

14:10

Moderators

Gerald R. Sydorak, MD, FACS
Seton Medical Center, Daly City, California, USA

Bijan Najafi, PhD, MSc
Baylor College of Medicine, Houston, Texas, USA

14:15

Device Induced Inflammation

Ulrike Klueh, PhD
Department of Biomedical Engineering, Integrative Biosciences Center, Wayne State University, Detroit, Michigan, USA

14:30

Identifying and Preventing Lipohypertrophy

Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES
Weill Cornell Medicine, Division of Endocrinology, Diabetes & Metabolism, New York City, New York, USA

14:45

Effects of Infusion Pumps

Jannet Svensson, MD, PhD
Steno Diabetes Center Copenhagen, Herlev, Denmark

14:55

Glycemic and Geriatric Challenges: Understanding Wound Healing Dynamics in Frail Diabetic Patients

Bijan Najafi, PhD, MSc
Baylor College of Medicine, Houston, Texas, USA

15:05

Q&A / Panel Discussion

15:20

Break

SESSION 12: HOT TOPICS

What are promising new technologies for diabetes?

15:40

Moderators

Umesh Masharani, MB, BS
University of California, San Francisco, San Francisco, California, USA

Geoff Chase, PhD
University of Canterbury, Christchurch, New Zealand

15:45

How Can Technology Improve Patient Adherence to Offloading?

Bijan Najafi, PhD, MSc
Baylor College of Medicine, Houston, Texas, USA

15:55

Peritoneal Insulin Delivery

Diane J. Burgess, PhD
University of Connecticut, Storrs, Connecticut, USA

16:05

Machine Learning for Multiple Sensor Datastreams and Explainable AI

Ali Cinar, PhD
Illinois Institute of Technology, Chicago, Illinois, USA

16:15

Green Diabetes

Ed Krisiunas, MLS(ASCP), MPH
WNWN International, Burlington, Connecticut, USA

16:25

Q&A / Panel Discussion

SESSION 13: LIVE DEMONSTRATION

What is a new carbohydrate dispensing product for diabetes?

16:40

Moderators

Dorian Liepmann, PhD
University of California, Berkeley, Berkeley, California, USA

Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES
Weill Cornell Medicine, Division of Endocrinology, Diabetes & Metabolism, New York City, New York, USA

16:45

House of Carbs - Personalized Carbohydrate Dispenser for People with Diabetes

Eirik Årsand, PhD
UiT Arctic University of Norway, Tromsø, Norway

Pietro Randine
UiT Arctic University of Norway, Tromsø, Norway

17:00

Closing Statement and Adjourn

David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA

Tuesday, November 7, 2023Free Session Registration

VIRTUAL POSTER SESSION (Non-Accredited Education)

Oral presentation and moderated discussion of the top abstracts submitted to DTM 2023

8:30-12:30

View Detailed Agenda